Viral Interleukin-6: Molecular Biology and Pathogenesis
Publisher
Springer New York
Reference58 articles.
1. Aoki, Y., Jaffe, E. S., Chang, Y., Jones, K., Teruya-Feldstein, J., Moore, P. S., and Tosato, G. (1999). Angiogenesis and hematopoiesis induced by Kaposi’s sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93, 4034–4043. 2. Aoki, Y., Narazaki, M., Kishimoto, T., and Tosato, G. (2001). Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus. Blood 98, 3042–3049. 3. Aoki, Y., and Tosato, G. (1999). Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi’s sarcoma-associated herpesvirus-infected primary effusion lymphomas. Blood 94, 4247–4254. 4. Aoki, Y., and Tosato, G. (2003). Targeted inhibition of angiogenic factors in AIDS-related disorders. Curr Drug Targets Infect Disord 3, 115–128. 5. Asou, H., Said, J. W., Yang, R., Munker, R., Park, D. J., Kamada, N., and Koeffler, H. P. (1998). Mechanisms of growth control of Kaposi’s sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood 91, 2475–2481.
|
|